MedPath

RSPR Pharma AB

RSPR Pharma AB logo
🇸🇪Sweden
Ownership
Private
Established
2006-01-01
Employees
1
Market Cap
-
Website
http://www.pulmologix.com

Clinical Trials

10

Active:4
Completed:6

Trial Phases

2 Phases

Phase 1:6
Phase 2:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (60.0%)
Phase 2
4 (40.0%)

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2015-11-25
Last Posted Date
2017-02-27
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
168
Registration Number
NCT02615080
Locations
🇧🇬

MHAT St. Ivan Rilski-2003 Ltd., Department of Internal Medicine, Dupnitsa, Bulgaria

🇧🇬

SHATPPD - Pazardzhik EOOD, Department of phthisiatrics pneumonia and pulmonary functional diagnostics, Pazardzhik, Bulgaria

🇧🇬

Medical Center - Razgrad OOD, Office of Pneumonology and Phthisiatry, Razgrad, Bulgaria

and more 19 locations

RSPR-007 Mannitol Challenge Trial

Phase 2
Completed
Conditions
Asthma
Interventions
Other: Placebo
First Posted Date
2015-11-20
Last Posted Date
2016-11-16
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
24
Registration Number
NCT02609334
Locations
🇩🇰

Hvidovre Hospital, Hvidovre, Denmark

🇩🇰

Bisbebjerg Hospital, København NV, Denmark

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2015-08-07
Last Posted Date
2015-08-07
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
24
Registration Number
NCT02517372

Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.

Phase 1
Completed
Conditions
Abdominal Aortic Aneurisms
Interventions
First Posted Date
2012-11-08
Last Posted Date
2012-11-29
Lead Sponsor
RSPR Pharma AB
Target Recruit Count
18
Registration Number
NCT01723618
Locations
🇩🇰

Department of Vascular Surgery Viborg Hospital, Viborg, Denmark

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Phase 2
Completed
Conditions
Becker Muscular Dystrophy
Duchenne Muscular Dystrophy
Interventions
First Posted Date
2012-02-29
Last Posted Date
2012-10-02
Lead Sponsor
RSPR Pharma AB
Registration Number
NCT01540604
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.